Stevanato Group Spa

Research Stevanato Group Spa (STVN) on Bullrun: valuation model: 3.3% undervalued, market cap USD 4.74B, P/E 28.9, dividend yield 0.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerSTVN
ExchangeNYSE
CountryItaly
SectorHealthcare
IndustryMedical Instruments & Supplies
CurrencyUSD
Valuation signal3.3% undervalued
Market capUSD 4.74B
P/E28.9
Dividend yield0.4%
Financial periodQ1 2026
RevenueUSD 273.57M
Net incomeUSD 28.03M
Free cash flow-USD 12.24M
Gross margin27.5%

Valuation Snapshot

Bullrun's latest valuation model marks Stevanato Group Spa as 3.3% undervalued; latest market cap is USD 4.74B; P/E is 28.9; dividend yield is 0.4%.

About Stevanato Group Spa

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions;

Frequently asked questions

Is Stevanato Group Spa overvalued or undervalued?

Bullrun's valuation model currently marks Stevanato Group Spa as 3.3% undervalued.

What is Stevanato Group Spa's market cap?

Stevanato Group Spa's market capitalization is USD 4.74B.

What is Stevanato Group Spa's P/E ratio?

Stevanato Group Spa's price-to-earnings (P/E) ratio is 28.9.

Does Stevanato Group Spa pay a dividend?

Stevanato Group Spa has a dividend yield of 0.4%.